Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Tsunoda

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Anticancer Research|April 28, 2025
Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine CarcinomaTakeshi Yamashita, Koichiro Fujimasa, Koji Otsuka, et al.
Anticancer Research|September 15, 2019
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint InhibitorsKiyohiro Ando, Kazuyuki Hamada, Makoto Watanabe, et al.
Pancreas|February 10, 2021
The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic CancerRyotaro Ohkuma, Yutaro Kubota, Atsushi Horiike, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2012
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapyHiroki Yoshioka, Shinji Yamamoto, Hirofumi Hanaoka, et al.
International Journal of Oncology|July 31, 2012
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancerToru Masuzawa, Yoshiyuki Fujiwara, Kaoru Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2023
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinomaYoko Yoshimaru, Katsuya Nagaoka, Kentaro Tanaka, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2019
Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancersTomohiro Kikuchi, Kosaku Mimura, Mai Ashizawa, et al.
International Journal of Cancer|August 19, 2009
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapyKazunori Yokomine, Satoru Senju, Tetsuya Nakatsura, et al.
Frontiers in Oncology|February 21, 2025
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort studyToshiaki Tsurui, Kazuyuki Hamada, Emiko Mura, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2020
A high number of PD-L1<sup>+</sup> CD14<sup>+</sup> monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitorsKiyohiro Ando, Kazuyuki Hamada, Midori Shida, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Anticancer Research|April 28, 2025
Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine CarcinomaTakeshi Yamashita, Koichiro Fujimasa, Koji Otsuka, et al.
Anticancer Research|September 15, 2019
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint InhibitorsKiyohiro Ando, Kazuyuki Hamada, Makoto Watanabe, et al.
Pancreas|February 10, 2021
The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic CancerRyotaro Ohkuma, Yutaro Kubota, Atsushi Horiike, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2012
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapyHiroki Yoshioka, Shinji Yamamoto, Hirofumi Hanaoka, et al.
International Journal of Oncology|July 31, 2012
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancerToru Masuzawa, Yoshiyuki Fujiwara, Kaoru Okada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2023
Randomized phase I/II study of vascular endothelial growth factor receptor peptide vaccines for patients with hepatocellular carcinomaYoko Yoshimaru, Katsuya Nagaoka, Kentaro Tanaka, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2019
Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancersTomohiro Kikuchi, Kosaku Mimura, Mai Ashizawa, et al.
International Journal of Cancer|August 19, 2009
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapyKazunori Yokomine, Satoru Senju, Tetsuya Nakatsura, et al.
Frontiers in Oncology|February 21, 2025
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort studyToshiaki Tsurui, Kazuyuki Hamada, Emiko Mura, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2020
A high number of PD-L1<sup>+</sup> CD14<sup>+</sup> monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitorsKiyohiro Ando, Kazuyuki Hamada, Midori Shida, et al.
Pageof 13